U.S. Alzheimers Linked Imaging Market Estimations (2025 - 2035)
The U.S. Alzheimers linked imaging market covers imaging services, radiotracers, scanners and software used to detect, stage and monitor Alzheimer's disease in the United States, including amyloid PET, tau PET, FDG PET and structural MRI scans, amyloid and tau radiotracers and AI volumetric and quantification software, for diagnosis, therapy eligibility and ARIA safety monitoring in hospitals, imaging centres and research sites.
📄Report ID:2501
|
📊Format: Databook
|
📅Published: 17 November 2026
|
⚡Delivery: Immediate